<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>ECMO complications</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">ECMO complications</h1>
<div class="graphic"><div class="figure"><div class="ttl">ECMO complications</div><div class="cntnt"><table cellspacing="0"><colgroup span="3" width="33%"></colgroup> <tbody> <tr> <td class="subtitle1_left">Neurologic</td> <td class="subtitle1_left" colspan="2">Hematologic</td> </tr> <tr> <td> <ul> <li>Intracranial bleeding<sup>*</sup></li> <li>Thromboembolic stroke</li> <li>Seizures (due to intracranial pathology)</li> </ul> </td> <td colspan="2"> <ul> <li>Hemorrhage<sup>*</sup> (cannula site, surgical site, GIB, pulmonary, CNS, RP)</li> <li>Hemolysis<sup>*</sup></li> <li>Disseminated intravascular coagulation</li> <li>DVT and thromboembolism (systemic, cardiac, or pulmonary)<sup>*</sup></li> <li>Thrombocytopenia (including HIT)</li> <li>Retroperitoneal hematoma</li> </ul> </td> </tr> <tr> <td class="subtitle1_left">Pulmonary</td> <td class="subtitle1_left" colspan="2">Device-related</td> </tr> <tr> <td> <ul> <li>Pulmonary hemorrhage<sup>*</sup></li> <li>Pulmonary embolism</li> <li>Pulmonary edema</li> </ul> </td> <td><strong>Cannula-related</strong> <ul> <li>Cannula misplacement</li> <li>Vessel perforation</li> <li>Cannula site bleeding<sup>*</sup> and infection</li> <li>Limb ischemia</li> <li>Compartment syndrome</li> <li>Cannula thrombosis</li> </ul> </td> <td><strong>Circuit-related</strong> <ul> <li>Thrombosis<sup>*</sup></li> <li>Oxygenator failure<sup>*</sup></li> <li>Air embolism</li> <li>Pump failure</li> <li>Hypothermia</li> <li>Altered pharmacokinetics (drug sequestration, altered volume of distribution)</li> <li>Recirculation</li> </ul> </td> </tr> <tr> <td class="subtitle1_left">Cardiac</td> <td class="subtitle1_left" colspan="2">Renal</td> </tr> <tr> <td> <ul> <li>Arrythmias (atrial or ventricular)<sup>*</sup></li> <li>Cardiac perforation</li> <li>Pericardial tamponade</li> <li>Congestive heart failure</li> <li>Ventricular distension</li> <li>Intracardiac thrombosis</li> </ul> </td> <td colspan="2" rowspan="3"> <ul> <li>Acute kidney injury</li> </ul> </td> </tr> <tr> <td class="subtitle1_left">Infections</td> </tr> <tr> <td> <ul> <li>Cannula insertion site</li> <li>Blood stream infection/bacteremia<sup>*</sup></li> </ul> </td> </tr> </tbody></table></div><div class="graphic_lgnd"><p>Most of these complications are applicable to V-V ECMO, V-A ECMO, and ECCO<sub>2</sub>R. However, the proportions of specific complications may be different among these modes. For example, arterial thromboembolism causing stroke and neurologic injury, pulmonary hemorrhage from poor left ventricular emptying, limb ischemia, and coronary or cerebral hypoxia are more likely to occur in patients receiving V-A ECMO while recirculation can only occur in V-V ECMO; the latter is more likely if the patient has a 2-site configuration, rather than single-site.</p>
Some complications not listed on the table may relate to the underling disorder or mechanical ventilation, such as barotrauma.</div><div class="graphic_footnotes"><p>CNS: central nervous system; DVT: deep venous thrombosis; ECCO<sub>2</sub>R: extracorporeal carbon dioxide removal; ECMO: extracorporeal membrane oxygenation; GIB: gastrointestinal bleeding; HIT: heparin-induced thrombocytopenia; RP: retroperitoneal; V-A: venoarterial; V-V: venovenous.</p>
* The asterisk indicates the most common complications, which are mostly due to bleeding or thrombosis and in the region of 3 to 5% in prevalence, some higher (eg, circuit clots, infections, arrythmias).</div><div id="graphicVersion">Graphic 140676 Version 2.0</div></div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
